Search by Drug Name or NDC
NDC 70710-1464-01 Haloperidol decanoate 100 mg/mL Details
Haloperidol decanoate 100 mg/mL
Haloperidol decanoate is a INTRAMUSCULAR INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Zydus Pharmaceuticals USA Inc.. The primary component is HALOPERIDOL DECANOATE.
MedlinePlus Drug Summary
Haloperidol injection and haloperidol extended-release injection are used to treat schizophrenia (a mental illness that causes disturbed or unusual thinking, loss of interest in life, and strong or inappropriate emotions). Haloperidol injection is also used to control motor tics (uncontrollable need to repeat certain body movements) and verbal tics (uncontrollable need to repeat sounds or words) in people who have Tourette's disorder (condition characterized by motor or verbal tics). Haloperidol is in a class of medications called conventional antipsychotics. It works by decreasing abnormal excitement in the brain.
Related Packages: 70710-1464-01Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Haloperidol Injection
Product Information
| NDC | 70710-1464 |
|---|---|
| Product ID | 70710-1464_fb9be645-3f94-4c69-9aca-148a03795a07 |
| Associated GPIs | 59100010302020 |
| GCN Sequence Number | 011876 |
| GCN Sequence Number Description | haloperidol decanoate VIAL 100 MG/ML INTRAMUSC |
| HIC3 | H7O |
| HIC3 Description | ANTIPSYCHOTICS,DOPAMINE ANTAGONISTS,BUTYROPHENONES |
| GCN | 14781 |
| HICL Sequence Number | 001660 |
| HICL Sequence Number Description | HALOPERIDOL DECANOATE |
| Brand/Generic | Generic |
| Proprietary Name | Haloperidol decanoate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Haloperidol decanoate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION |
| Route | INTRAMUSCULAR |
| Active Ingredient Strength | 100 |
| Active Ingredient Units | mg/mL |
| Substance Name | HALOPERIDOL DECANOATE |
| Labeler Name | Zydus Pharmaceuticals USA Inc. |
| Pharmaceutical Class | Typical Antipsychotic [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA211180 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 70710-1464-01 (70710146401)
| NDC Package Code | 70710-1464-1 |
|---|---|
| Billing NDC | 70710146401 |
| Package | 1 VIAL, MULTI-DOSE in 1 CARTON (70710-1464-1) / 5 mL in 1 VIAL, MULTI-DOSE |
| Marketing Start Date | 2019-11-14 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 26.499 |
| Pricing Unit | ML |
| Effective Date | 2023-12-20 |
| NDC Description | HALOPERIDOL DEC 500 MG/5 ML VL |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4, 5 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |